Restricted accessResearch articleFirst published online 2024-02
Characterization of Verona Integron-Encoded Metallo-β-Lactamase-Type Carbapenemase-Producing Escherichia coli Isolates Collected over a 16-Year Period in Bolzano (Northern Italy)
Multidrug-resistant Escherichia coli, particularly carbapenemase producers, are a major source of concern. This study aims to investigate the long-term epidemiology of Verona integron-encoded metallo-β-lactamase (VIM)-producing E. coli in the health district of Bolzano, Northern Italy, by examining the phenotypic and genotypic characteristics of 26 isolates obtained during 2005–2020. Isolates were identified with matrix-assisted laser desorption/ionization time-of-flight, susceptibility testing was by Vitek 2, Sensititre, and Etest; carbapenemase activity was confirmed by Etest and Carbapenemase Inactivation Method (CIM) test; and the VIM-antigen was identified by the NG-Test CARBA 5. Genome sequencing was performed on an Illumina MiSeq platform. Carbapenem minimum inhibitory concentrations varied across methodologies, and overall category agreement between phenotypic methods was low. All 23 sequenced isolates contained blaVIM-1. Eleven (47.8%) isolates belonged to the clonal lineage ST131, with fimH30 being the most common subclone. In Bolzano ST131-fimH30 was present as early as 2005. While the ST131 clonal lineage predominated for the first 10 years, various clonal lineages were present, especially in subsequent years, indicating the concurrent circulation of multiple clonal lineages. Future efforts should focus on the implementation of surveillance methods, including genomic analysis, as well as the use of updated infection control strategies and antibiotic stewardship programs to prevent the spread of these carbapenem-resistant strains.
Get full access to this article
View all access options for this article.
References
1.
GianiT, AntonelliA, CaltagironeM, et al.Evolving beta-lactamase epidemiology in Enterobacteriaceae from Italian nationwide surveillance, October 2013: KPC-carbapenemase spreading among outpatients. Euro Surveill, 2017; 22(31); doi: 10.2807/1560-7917.ES.2017.22.31.30583
2.
SimoniS, CaucciS, BrencianiA, et al.Increase and diversity of carbapenemase-producing Escherichia coli isolates, Italy. Future Microbiol, 2019; 14:1035–1042.
3.
AschbacherR, DoumithM, LivermoreDM, et al.Linkage of acquired quinolone resistance (qnrS1) and metallo-beta-lactamase (blaVIM-1) genes in multiple species of Enterobacteriaceae from Bolzano, Italy. J Antimicrob Chemother, 2008; 61:515–523.
4.
MarchA, AschbacherR, DhanjiH, et al.Colonization of residents and staff of a long-term-care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria. Clin Microbiol Infect, 2010; 16:934–944.
5.
AschbacherR, PaganiL, DoumithM, et al.Metallo-β-lactamases among Enterobacteriaceae from routine samples in an Italian tertiary-care hospital and long-term care facilities during 2008. Clin Microbiol Infect, 2011; 17:181–189.
6.
AschbacherR, GianiT, CordaD, et al.Carbapenemase-producing Enterobacteriaceae during 2011–12 in the Bolzano area (Northern Italy): increasing diversity in a low-endemicity setting. Diagn Microbiol Infect Dis, 2013; 77:354–356.
7.
MarchA, AschbacherR, SleghelF, et al.Colonization of residents and staff of an Italian long-term care facility and an adjacent acute care hospital geriatric unit by multidrug-resistant bacteria. New Microbiol, 2017; 40(4):258–263.
8.
MarchA, AschbacherR, PaganiE, et al.Changes in colonization of residents and staff of a long-term care facility and an adjacent acute-care hospital geriatric unit by multidrug-resistant bacteria over a four-year period. Scand J Infect Dis, 2014; 46:114–122.
9.
AccogliM, GianiT, MonacoM, et al.Emergence of Escherichia coli ST131 sub-clone H30 producing VIM-1 and KPC-3 carbapenemases, Italy. J Antimicrob Chemother, 2014; 69:2293–2296.
10.
Nicolas-ChanoineMH, BlancoJ, Leflon-GuiboutV, et al.Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother, 2008; 61:273–281.
11.
MathersAJ, PeiranoG, PitoutJD. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev, 2015; 28:565–591.
JohnsonJR, TchesnokovaV, JohnstonB, et al.Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J Infect Dis, 2013; 207:919–928.
14.
PoirelL, NaasT, NicolasD, et al.Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother, 2000; 44:891–897.
15.
European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 12.0, 2022. Available from: www.EUCAST.org [Last accessed: May30, 2023].
16.
Van der ZwaluwK, de HaanA, PluisterGN, et al.The carbapenem inactivation method (CIM), a simple and low cost alternative for the carba NP test to assess phenotypic carbapenemase activity in Gram-negative rods. PLoS One, 2015; doi: 10.1371/journal.pone.0123690
17.
ISO 20776-2. Clinical laboratory testing and in vitro diagnostic test systems—Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices—Part 2: evaluation of performance of antimicrobial susceptibility test devices. 2007.
18.
DavisJJ, WattanAR, AzizRK, et al.The PATRIC Bioinformatics Resource Center: expanding data and analysis capabilities. Nucleic Acids Res, 2020; 48:Database issue; doi: 10.1093/nar/gkz943
19.
LarsenMV, CosentinoS, RasmussenS, et al.Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol, 2012; 50(4):1355–1361.
20.
RoerL, TchesnokovaV, AllesøeR, et al.Development of a web tool for Escherichia coli subtyping based on fimH alleles. J Clin Microbiol, 2017; 55(8):2538–2543.
21.
BortolaiaV, KaasRS, RuppeE, et al.ResFinder 4.0 for predictions of phenotypes from genotypes. J Antimicrobial Chemother, 2020; 75(12):3491–3500: doi: 10.1093/jac/dkaa345
22.
Malberg TetzschnerAM, JohnsonJR, JohnstonBD, et al.In silico genotyping of Escherichia coli isolates for extraintestinal virulence genes by use of Whole-Genome Sequencing data. J Clin Micobiol, 2020; 58(10):e01269-20; doi: 10.1128/JCM.01269-20
23.
CarattoliA, ZankariE, García-FernándezA, et al.In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother, 2014; 58(7):3895–3903.
24.
Seemann SnippyT.: Rapid Haploid Variant Calling and Core PhylogenySNP. 2015. Available from: https://github.com/tseemann/snippy [Last accessed: May 30, 2023].
25.
PriceMN, DehalPS, ArkinAP. 2009. FastTree: Computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol, 2009; 26(7):1641–1650; doi: 10.1093/molbev/msp077
26.
LetunicI, BorkP. Interactive Tree Of Life (iTOL) v5: An online tool for phylogenetic tree display and annotation. Nucleic Acids Res, 2021; 49(W1):W293–W296; doi: 10.1093/nar/gkab301
27.
GalesAC, StoneG, SahmDF, et al.Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: Results from ATLAS 2017–2019. J Antimicrob Chemother, 2023; 78(7):1606–1615; doi: 10.1093/jac/dkad127
28.
Del FrancoM, PaoneL, NovatiR, et al.Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d'Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789). BMC Microbiol, 2015; 15:260; doi: 10.1186/s12866-015-0597-z
29.
BarbariniD, RusselloG, BrovaroneF, et al.Evaluation of carbapenem-resistant Enterobacteriaceae in an Italian setting: Report from the trench. Infect Genet Evol, 2015; 30:8–14.
30.
GiufrèM, RicchizziE, AccogliM, et al.Colonization by multidrug-resistant organisms in long-term care facilities in Italy: A point-prevalence study. Clin Microbiol Infect, 2017;pii: S1198-743X(17)30211–2.
31.
CherubiniS, PerilliM, AzziniAM, et al.Ltcf-Veneto Working Group, Lo Cascio G. Resistome and virulome of Multi-Drug Resistant E. coli ST131 isolated from residents of Long-Term Care Facilities in the Northern Italian Region. Diagnostics (Basel), 2022; 16;12(1):213.
32.
AntonelliA, CoppiM, CamarlinghiG, et al.Variable performance of different commercial systems for testing carbapenem susceptibility of KPC carbapenemase-producing Escherichia coli. Clin Microbiol Infect, 2019; 25(11):1432.e1–1432.e4; doi: 10.1016/j.cmi.2019.08.005
33.
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Approved Standard M100-Ed32. CLSI: Wayne, PA; 2022.
34.
LivermoreDM, AndrewsJM, HawkeyPM, et al.Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?. J Antimicrob Chemother, 2012; 67:1569–1577.
MantengoliE, LuzzaroF, PecileP, et al.Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: Further narrowing of treatment options. Clin Infect Dis, 2011; 52:690–691.
37.
CarattoliA, AschbacherR, MarchA, et al.Complete nucleotide sequence of the IncN plasmid pKOX105 encoding VIM-1, QnrS1 and SHV-12 proteins in Enterobacteriaceae from Bolzano, Italy compared with IncN plasmids encoding KPC enzymes in the USA. J Antimicrob Chemother, 2010; 65:2070–2075.
38.
FascianaT, GiordanoG, Di CarloP, et al.Virulence factors and antimicrobial resistance of Escherichia coli ST131 in community-onset healthcare-associated infections in Sicily, Italy. Pharmacologyonline, 2017; 1:12–21.
39.
MoonDC, SeolSY, GurungM, et al.Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates. Int J Antimicrob Agents, 2010; 35:76–79.
40.
European Committee on Antimicrobial Susceptibility Testing (EUCAST). Ciprofloxacin: Rationale for EUCAST Clinical Breakpoint. Version 2.0. 2021. Available from: https://www.eucast.org/publications-and-documents/rd [Last accessed: May30, 2023].
41.
SuzukiS, HorinouchiT, FurusawaC. Prediction of antibiotic resistance by gene expression profiles. Nat Commun, 2014; 5:5792; doi: 10.1038/ncomms6792
42.
KimSY, ParkYJ, YuJK, et al.Aminoglycoside susceptibility profiles of Enterobacter cloacae isolates harboring the aac(6′)-Ib gene. Korean J Lab Med, 2011; 31:279–281.
43.
GiufrèM, ErricoG, MonacoM, et al.Whole genome sequencing and molecular analysis of carbapenemase-producing Escherichia coli from intestinal carriage in elderly inpatients. Microorganisms, 2022; 10:1561.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
